Lv1
30 积分 2024-03-15 加入
Pan-cancer analysis of oncogenic MET fusions reveals distinct pathogenomic subsets with differential sensitivity to MET-targeted therapy
2天前
已完结
Consensus on the management of cutaneous adverse reactions to anti-tumor drugs
4天前
已完结
Brief Report: Osimertinib Plus Capmatinib for Patients with MET-Altered EGFR-Mutant NSCLC following progression on front line therapy
1个月前
已完结
CRE25-033: A MET Amplified Metastatic Esophageal Adenocarcinoma Demonstrates Response to the MET Inhibitor Capmatinib
1个月前
已关闭
Antitumor Activity of a Bispecific Chimera Targeting EGFR and Met in Gefitinib‐Resistant Non‐Small Cell Lung Cancer
1个月前
已完结
MET Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression
1个月前
已完结
c-Met immunohistochemistry as reflex test at diagnosis for non-small cell lung cancer: a real-world experience from a monocentric case series
1个月前
已完结
MET immunolabelling is a useful predictive tool for MET gene amplification in glioblastoma
1个月前
已完结
Development and clinical significance of FISH technique for detecting PTPRZ1-MET fusion gene in glioma patients
2个月前
已完结
Use of Cabozantinib to Treat MET-amplified Pediatric Colorectal Cancer
2个月前
已完结
皖公网安备34019202002308
